Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECANSII: Aripiprazole in First-Episode Schizophrenia
NCT02339844Phase 4Completed
- Sponsor
- University of Copenhagen
- Start
- Jan 2014
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia, schizoaffective disorder, sponsored by University of Copenhagen. Started Jan 2014; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02339844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339844.